Medicine Price Surveys, Analyses and Comparisons

  • ID: 4430030
  • Book
  • 300 Pages
  • Elsevier Science and Technology
1 of 4

Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance establishes guiding principles for the study and implementation of pharmaceutical price surveys, analyses and comparisons. The book reviews current price studies in major pharmaceutical markets, accounting for the impact of methodological choices on findings, and explaining how, and why, differences in medicine prices manifest between, and within, different regions. The book provides practical guidance on how to conduct meaningful price analyses and comparisons, evaluates the existing price survey literature, discusses the accessibility and reliability of data sources, and provides a checklist and training kit on price surveys, analyses and comparisons.

In addition, the book devotes time to the theory and practice of external price comparisons and their benefits and limitations. Finally, the impact of the design of external price referencing on policy objectives, such as affordable access to medicines and cost-containment are discussed, along with options for improving the effectiveness of policies.

  • Provides practical guidance on how to plan and implement pharmaceutical pricing policies and systems
  • Reviews the use, practice and experience of external price referencing systems across the world
  • Explains how to interpret medicine price surveys using common baselines
  • Simplifies the complexities of pharmaceutical price terminology and nomenclature
Note: Product cover images may vary from those shown
2 of 4

1. Introduction 2. Regional and international comparison of medicine prices 3. Price studies for specific medicines 4. Developments 5. Discussion of methodology and findings 6. Overview of existing methodologies 7. Terminology 8. Medicine price data sources 9. Planning price studies 10. Interpretation of price analyses 11. Price comparison as one pricing 12. Practice of external price referencing 13. Assessment of EPR 14. Policy guidance 15. Policy brief 16. Conclusions

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Vogler, Sabine
Sabine Vogler is Head of the Pharmacoeconomics Department at the Austrian Public Health Institute, and Head of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies affiliated to the Pharmacoeconomics Department. As a senior researcher working in this area for more than two decades, she has expertise and in-depth knowledge about European countries with regard to pharmaceutical pricing/prices, reimbursement and distribution, as well as cost-containment reforms, access and affordability issues. The Pharmacoeconomics department runs the Pharma Price Information (PPI) service that provides medicine price information for 30 European countries, and Dr Vogler and her team use PPI to support public pricing authorities as well as for research purposes.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll